Partner With TauRx
TauRx has a strong and defensible intellectual property position having focused for nearly 3 decades in researching tau pathology of Alzheimer’s and other neurodegenerative diseases. Professor Wischik’s team has generated a multi-layered portfolio of patents and patent applications consisting of over 836 granted patents and 120 pending. The core patents provide cover through 2032 and beyond.
Having pioneered a potential new pathway towards effective treatment and prevention of Alzheimer’s, the company’s success to date is also due to collaborations with organisations that span a variety of fields. Achieving the company’s long term vision and commercial goals will require further alliances and TauRx is pleased to consider new partnerships with organisations active in the field of neurodegeneration.
Should you match the business development interests of TauRx as outlined above please contact us.